Compounds for the treatment of hepatitis B virus infection
US10100052B2 · kind B2 · utility
0Cited by
1References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 16, 2017 |
| Grant date | Oct 16, 2018 |
| Priority date | — |
| Expiry date | May 16, 2037 |
Classification
- Technology area (CPC —)General
Abstract
The present disclosure generally relates to compounds and pharmaceutical compositions which may be used in methods of treating a hepatitis B virus infection.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.